KENNETH MICHEFF: Open Payments
NPI 1649677709 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 19 payments from 11 companies in 2025. Trend: 2023 $631 · 2024 $1,025 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $243 |
| Regeneron Healthcare Solutions, Inc. | 6 | $152 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| GENZYME CORPORATION | 1 | $42 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: RINVOQ, LIBTAYO, SKYRIZI, DUPIXENT, COSENTYX, ILUMYA, Cabtreo, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
